We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review

Published: July 2019
Pages: 39
Code: 012755B3ACAE660B4627F9031DA1A20D
Format: PDF
Publisher GlobalData
From Add to basket
$ 125.00
Provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Additonal Information

  • - Business description – A detailed description of the company’s operations and business divisions.
  • - Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • - Company history – Progression of key events associated with the company.
  • - Major products and services – A list of major products, services and brands of the company.
  • - Key competitors – A list of key competitors to the company.
  • - Key employees – A list of the key executives of the company.
  • - Executive biographies – A brief summary of the executives’ employment history.
  • - Key operational heads – A list of personnel heading key departments/functions.
  • - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
  • Highlights
  • NovanInc (Novan) is a biotechnology company that develops nitric oxide therapies for the treatment of diseases with unmet needs. The company’s products find application in the treatment of dermatology disorders, gastroenterology and women’s health. Its pipeline products focus on treating acne vulgaris, external genital warts,onychomycosis, psoriasis and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in collaboration with academic institutions, public and private companies and other universities. Novan is headquartered in Morrisville, North Carolina, the US.
  • Novan Inc Key Recent Developments
  • Jun 19,2019: Novan expands external business partner network
  • Jan 02,2019: Novan announces management changes and provides business update
  • Apr 12,2018: Novan Advances Organization and Strengthens Leadership Team
  • Feb 21,2018: Dr. Eugene Sun Appointed to Novan Board of Directors
  • Jan 19,2018: Novan Announces Resignation Of William L. Hodges As Interim Chief Financial Office

Companies Mentioned

Melinta Therapeutics Inc
AnaptysBio Inc
ImmunoGen Inc
Vaxart Inc
Helix BioMedix Inc
Mycovia Pharmaceuticals Inc

Reasons to buy

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company
Add to basket
  • Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Section 1 - About the Company
  • Novan Inc - Key Facts
  • Novan Inc - Key Employees
  • Novan Inc - Key Employee Biographies
  • Novan Inc - Major Products and Services
  • Novan Inc - History
  • Novan Inc - Company Statement
  • Novan Inc - Locations And Subsidiaries
  • Head Office
  • Section 2 – Company Analysis
  • Company Overview
  • Novan Inc - Business Description
  • R&D Overview
  • Novan Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Novan Inc - Strengths
  • Novan Inc - Weaknesses
  • Novan Inc - Opportunities
  • Novan Inc - Threats
  • Novan Inc - Key Competitors
  • Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Novan Inc, Recent Deals Summary
  • Section 5 – Company’s Recent Developments
  • Jun 19, 2019: Novan expands external business partner network
  • Jan 02, 2019: Novan announces management changes and provides business update
  • Apr 12, 2018: Novan Advances Organization and Strengthens Leadership Team
  • Feb 21, 2018: Dr. Eugene Sun Appointed to Novan Board of Directors
  • Jan 19, 2018: Novan Announces Resignation Of William L. Hodges As Interim Chief Financial Office
  • Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • List of Tables
  • Novan Inc, Key Facts
  • Novan Inc, Key Employees
  • Novan Inc, Key Employee Biographies
  • Novan Inc, Major Products and Services
  • Novan Inc, History
  • Novan Inc, Key Competitors
  • Novan Inc, Ratios based on current share price
  • Novan Inc, Annual Ratios
  • Novan Inc, Annual Ratios (Cont...1)
  • Novan Inc, Interim Ratios
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Novan Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Novan Inc, Performance Chart (2014 - 2018)
  • Novan Inc, Ratio Charts
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Keywords
;